Recovery & Repair
ARA-290
EPO-derived helix-B peptide
Quality assurance
Documented, not promised.
Every batch is tested by an independent laboratory and released with a public certificate of analysis. Every insert carries a unique verification code.
- COA & HPLC verified for every batch
- Independent third-party laboratory testing
- For laboratory and research use only
Overview
ARA-290 — EPO-derived helix-B peptide
What is ARA-290?
ARA-290 (cibinetide) is an 11-residue peptide derived from the helix-B surface of erythropoietin. It was designed to engage the tissue-protective innate-repair receptor while leaving EPO's blood-cell-stimulating activity behind — which is exactly what makes it interesting: the repair signalling, isolated from the hematopoietic one.
Why researchers choose it
ARA-290 lets protocols study EPO-pathway tissue protection without the confound of erythropoiesis, a separation the parent hormone cannot offer. It has a substantial research literature in neuropathy and tissue-protection models. REPRIME supplies a lyophilized 30 mg vial — generous capacity for extended protocols, with reconstitution under the researcher's control.
The REPRIME standard
Engineered selectivity deserves verified identity. Every batch is independently HPLC-tested and released at ≥99% main-peak purity, with the batch COA published in the Certificates repository. The 30 mg lyophilized vial ships cold-chain in tamper-evident packaging with a unique REP-XXXX-XXXX-X code — one scan at first use confirms it is genuine. For laboratory and research use only; not for human consumption.
Storage
Store lyophilized at -20°C. After reconstitution, refrigerate at 2-8°C.
Research use only
For laboratory and research use only. Not for human or animal consumption.
Documents
Lab reports for this batch.
Documents will appear here once the lab reports are uploaded.
FAQ
Frequently asked questions.
What is ARA-290?+
An 11-residue peptide derived from erythropoietin's helix-B surface, studied for tissue-protective signalling separated from EPO's blood-cell effects.
How is ARA-290 supplied?+
As a lyophilized 30 mg vial, HPLC-verified at ≥99% purity with a batch-specific COA and verification code.